Skip to content

Progression in brain abnormalities in psychosis: a 12-year follow-up study

Progression in brain abnormalities in psychosis: a 12-year follow-up study - Longitudinal MRI in psychosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON31380
Enrollment
600
Registered
2008-02-05
Start date
2008-03-01
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychose - delusions

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Subjects have to satisfy the following criteria in order to participate in the study: - Do not have a pacemaker - Do not have metal materials in the head (except for dental braces) - Give written informed consent - Do not have a major medical history;Specific for patients: - Do have a DSM-IV diagnosis of Schizophrenia, Schizoaffective disorder or Bipolar disorder, or expereince a first psychotic episode - Do not chronically use medication, other than psychiatric medication - Unable to give consent;Specific to healthy subjects: - Do not have a psychiatric history - Do not have a first-degree family member with a psychiatric illness - Do not chronically use medication

Exclusion criteria

Exclusion criteria: - Ferrous objects in or around the body (e.g. braces, glasses, pacemaker, metal fragments) - Drug or alcohol abuse over a period of six months prior to the experiment - History of closed-head injury - History of neurological illness or endocrinological dysfunction - Claustrophobia

Design outcomes

Primary

MeasureTime frame
What are the age-related trajectories of brain change in patients with schizophrenia, schizoaffective disorder, or bipolar disorder, relative to healthy individuals?

Secondary

MeasureTime frame
Are the age-related brain changes seen in patients clinically relevant, i.e. the association with medication intake, outcome and symptoms will be tested. Can the age-related brain changes be explained by genetic or environmental factors?

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)